The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Open accessAbstract
BACKGROUND: Buprenorphine maintenance treatment has been evaluated in randomised controlled trials against placebo medication, and separately as an alternative to methadone for management of opioid dependence. OBJECTIVES: To evaluate buprenorphine maintenance compared to placebo and to methadone maintenance in the management of opioid dependence, including its ability to retain people in treatment, suppress illicit drug use, reduce criminal activity, and mortality. SEARCH METHODS: We searched the following databases to January 2013: Cochrane Drugs and Alcohol Review Group Specialised Register, Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, Current Contents, PsycLIT, CORK, Alcohol and Drug Council of Australia, Australian Drug Foundation, Centre for Education and Information on Drugs and Alcohol, Library of Congress, reference lists of identified studies and reviews. We sought published/unpublished randomised controlled trials (RCTs) from authors. SELECTION CRITERIA: Randomised controlled trials of buprenorphine maintenance treatment versus placebo or methadone in management of opioid-dependent persons. DATA COLLECTION AND ANALYSIS: We used Cochrane Collaboration methodology. MAIN RESULTS: We include 31 trials (5430 participants), the quality of evidence varied from high to moderate quality.There is high quality of evidence that buprenorphine was superior to placebo medication in retention of participants in treatment at all doses examined. Specifically, buprenorphine retained participants better than placebo: at low doses (2 - 6 mg), 5 studies, 1131 participants, risk ratio (RR) 1.50; 95% confidence interval (CI) 1.19 to 1.88; at medium doses (7 - 15 mg), 4 studies, 887 participants, RR 1.74; 95% CI 1.06 to 2.87; and at high doses (≥ 16 mg), 5 studies, 1001 participants, RR 1.82; 95% CI 1.15 to 2.90. However, there is moderate quality of evidence that only high-dose buprenorphine (≥ 16 mg) was more effective than placebo in suppressing illicit opioid use measured by urinanalysis in the trials, 3 studies, 729 participants, standardised mean difference (SMD) -1.17; 95% CI -1.85 to -0.49, Notably, low-dose, (2 studies, 487 participants, SMD 0.10; 95% CI -0.80 to 1.01), and medium-dose, (2 studies, 463 participants, SMD -0.08; 95% CI -0.78 to 0.62) buprenorphine did not suppress illicit opioid use measured by urinanalysis better than placebo.There is high quality of evidence that buprenorphine in flexible doses adjusted to participant need,was less effective than methadone in retaining participants, 5 studies, 788 participants, RR 0.83; 95% CI 0.72 to 0.95. For those retained in treatment, no difference was observed in suppression of opioid use as measured by urinalysis, 8 studies, 1027 participants, SMD -0.11; 95% CI -0.23 to 0.02 or self report, 4 studies, 501 participants, SMD -0.11; 95% CI -0.28 to 0.07, with moderate quality of evidence.Consistent with the results in the flexible-dose studies, in low fixed-dose studies, methadone (≤ 40 mg) was more likely to retain participants than low-dose buprenorphine (2 - 6 mg), (3 studies, 253 participants, RR 0.67; 95% CI: 0.52 to 0.87). However, we found contrary results at medium dose and high dose: there was no difference between medium-dose buprenorphine (7 - 15 mg) and medium-dose methadone (40 - 85 mg) in retention, (7 studies, 780 participants, RR 0.87; 95% CI 0.69 to 1.10) or in suppression of illicit opioid use as measured by urines, (4 studies, 476 participants, SMD 0.25; 95% CI -0.08 to 0.58) or self report of illicit opioid use, (2 studies, 174 participants, SMD -0.82; 95% CI -1.83 to 0.19). Similarly, there was no difference between high-dose buprenorphine (≥ 16 mg) and high-dose methadone (≥ 85 mg) in retention (RR 0.79; 95% CI 0.20 to 3.16) or suppression of self-reported heroin use (SMD -0.73; 95% CI -1.08 to -0.37) (1 study, 134 participants).Few studies reported adverse events ; two studies compared adverse events statistically, finding no difference between methadone and buprenorphine, except for a single result indicating more sedation among those using methadone. AUTHORS' CONCLUSIONS: Buprenorphine is an effective medication in the maintenance treatment of heroin dependence, retaining people in treatment at any dose above 2 mg, and suppressing illicit opioid use (at doses 16 mg or greater) based on placebo-controlled trials.However, compared to methadone, buprenorphine retains fewer people when doses are flexibly delivered and at low fixed doses. If fixed medium or high doses are used, buprenorphine and methadone appear no different in effectiveness (retention in treatment and suppression of illicit opioid use); however, fixed doses are rarely used in clinical practice so the flexible dose results are more relevant to patient care. Methadone is superior to buprenorphine in retaining people in treatment, and methadone equally suppresses illicit opioid use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Self-citation(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_6514 · Cited by 1,385
A double‐blind, placebo‐controlled trial
Pinals, R. S., Kaplan, S. B., Lawson, J. G., & Hepburn, B. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291202 · Cited by 1,355
Extent of illicit drug use and dependence, and their contribution to the global burden of disease
Degenhardt, L., & Hall, W. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61138-0 · Cited by 1,303
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., Wodak, A., Panda, S., Tyndall, M., Toufik, A., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61311-2 · Cited by 1,285
Self-citationNelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61097-0 · Cited by 1,267
Dole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005359 · Cited by 986
Degenhardt, L., Bucello, C., Mathers, B., Briegleb, C., Ali, H., Hickman, M., & McLaren, J. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03140.x · Cited by 856
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R., Fry-Smith, A., Day, E., Lintzeris, N., Roberts, T., et al. (2007) · Health Technology Assessment · doi:10.3310/hta11090 · Cited by 585
Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., Collins, J., Raisch, D., Casadonte, P., Goldsmith, R. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022164 · Cited by 577
A Controlled Trial of Buprenorphine Treatment for Opioid Dependence
Johnson, R. E. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480200058024 · Cited by 572
Weiss, R. D. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.121 · Cited by 540
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
Self-citationKakko, J., Svanborg, K. D., Kreek, M. J., & Heilig, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12600-1 · Cited by 466
Methadone maintenance at different dosages for opioid dependence
Faggiano, F., Vigna-Taglianti, F., Versino, E., & Lemma, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002208 · Cited by 406
Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial
Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Kintaudi, P., Wesson, D. R., Mcnicholas, L., Tusel, D. J., Malkerneker, U., et al. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9344753.x · Cited by 402
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366
Woody, G. E., Poole, S. A., Subramaniam, G., Dugosh, K., Bogenschutz, M., Abbott, P., Patkar, A., Publicker, M., McCain, K., Potter, J. S., et al. (2008) · JAMA · doi:10.1001/jama.2008.574 · Cited by 361
Degenhardt, L., Randall, D., Hall, W., Law, M., Butler, T., & Burns, L. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.05.021 · Cited by 338
Comparison of buprenorphine and methadone in the treatment of opioid dependence
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.1025 · Cited by 305
Buprenorphine vs Methadone Maintenance Treatment for Concurrent Opioid Dependence and Cocaine Abuse
Schottenfeld, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200041006 · Cited by 303
Jones, H. E., Johnson, R. E., Jasinski, D. R., O’Grady, K. E., Chisholm, C. A., Choo, R. E., Crocetti, M., Dudas, R., Harrow, C., Huestis, M. A., et al. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.11.013 · Cited by 295
Clausen, T., Anchersen, K., & Waal, H. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.11.003 · Cited by 287
Mattick, R. P., Ali, R., White, J. M., O'Brien, S., Wolk, S., & Danz, C. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00335.x · Cited by 285
Self-citationPerneger, T. V., Giner, F., del Rio, M., & Mino, A. (1998) · BMJ · doi:10.1136/bmj.317.7150.13 · Cited by 278
Buprenorphine versus Methadone Maintenance for Opioid Dependence
KOSTEN, T. R., SCHOTTENFELD, R., ZIEDONIS, D., & FALCIONI, J. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199306000-00004 · Cited by 267
A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts
Bickel, W. K., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D. R., & Johnson, R. E. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.13 · Cited by 260
Maintenance agonist treatments for opiate dependent pregnant women
Minozzi, S., Amato, L., Vecchi, S., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub2 · Cited by 238
Self-citationMethadone versus buprenorphine in pregnant addicts: a double‐blind, double‐dummy comparison study
Fischer, G., Ortner, R., Rohrmeister, K., Jagsch, R., Baewert, A., Langer, M., & Aschauer, H. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01321.x · Cited by 236
Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial
Magura, S., Lee, J. D., Hershberger, J., Joseph, H., Marsch, L., Shropshire, C., & Rosenblum, A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.006 · Cited by 223
Kakko, J., Grönbladh, L., Svanborg, K. D., von Wachenfeldt, J., Rück, C., Rawlings, B., Nilsson, L.-H., & Heilig, M. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.5.797 · Cited by 197
Exposure to opioid maintenance treatment reduces long‐term mortality
Gibson, A., Degenhardt, L., Mattick, R. P., Ali, R., White, J., & O'Brien, S. (2008) · Addiction · doi:10.1111/j.1360-0443.2007.02090.x · Cited by 194
Self-citationFudala, P. J., Jaffe, J. H., Dax, E. M., & Johnson, R. E. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.67 · Cited by 191
Soyka, M., Zingg, C., Koller, G., & Kuefner, H. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570700836x · Cited by 184
A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence
Johnson, R. E., Eissenberg, T., Stitzer, M. L., Strain, E. C., Liebson, I. A., & Bigelow, G. E. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01186-2 · Cited by 183
O’Connor, P., Oliveto, A., Shi, J., Triffleman, E., Carroll, K., Kosten, T., Rounsaville, B., Pakes, J., & Schottenfeld, R. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00194-6 · Cited by 174
Buprenorphine Implants for Treatment of Opioid Dependence: A Randomized Controlled Trial
Ling, W., Casadonte, P., Bigelow, G., Kampman, K. M., Patkar, A., Bailey, G. L., Rosenthal, R. N., & Beebe, K. L. (2010) · JAMA · doi:10.1001/jama.2010.1427 · Cited by 171
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence
Pani, P., Maremmani, I., Pirastu, R., Tagliamonte, A., & Gessa, G. L. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00140-4 · Cited by 169
Double-blind randomized trial of buprenorphine and methadone in opiate dependence
Petitjean, S. A., Stohler, R., Déglon, J., Livoti, S., Waldvogel, D., Uehlinger, C., & Ladewig, D. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00163-0 · Cited by 169
Buprenorphine versus methadone maintenance for the treatment of opioid dependence
Fischer, G., Gombas, W., Eder, H., Jagsch, R., Peternell, A., Stuhlinger, G., Pezawas, L., Aschauer, H. N., & Kasper, S. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.94913376.x · Cited by 164
Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome
Gerra, G., Borella, F., Zaimovic, A., Moi, G., Bussandri, M., Bubici, C., & Bertacca, S. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.11.017 · Cited by 161
Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence
Montoya, I. D., Gorelick, D. A., Preston, K. L., Schroeder, J. R., Umbricht, A., Cheskin, L. J., Lange, W. R., Contoreggi, C., Johnson, R. E., & Fudala, P. J. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.09.004 · Cited by 159
Maintenance agonist treatments for opiate-dependent pregnant women
Minozzi, S., Amato, L., Bellisario, C., Ferri, M., & Davoli, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006318.pub3 · Cited by 159
Self-citationSchottenfeld, R. S., Chawarski, M. C., Pakes, J., Pantalon, M. V., Carroll, K. M., & Kosten, T. R. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.2.340 · Cited by 155
Strain, E., Stitzer, M., Liebson, I., & Bigelow, G. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199602000-00010 · Cited by 153
A meta‐analysis comparing buprenorphine to methadone for treatment of opiate dependence
Barnett, P. G., Rodgers, J. H., & Bloch, D. A. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.9656834.x · Cited by 150
Giacomuzzi, S. M., Riemer, Y., Ertl, M., Kemmler, G., Rößler, H., Hinterhuber, H., & Kurz, M. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00352.x · Cited by 126
Methadone Toxicity Causing Death in Ten Subjects Starting on a Methadone Maintenance Program
Drummer, O. H., Opeskin, K., Syrjanen, M. L., & Cordner, S. M. (1992) · American Journal of Forensic Medicine & Pathology · doi:10.1097/00000433-199212000-00017 · Cited by 122
Clinical efficacy of buprenorphine: comparisons to methadone and placebo
LING, W. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00059-0 · Cited by 121
Lucas, G. M., Chaudhry, A. A., Hsu, J., Woodson, T., Lau, B. M., Olsen, Y. K., Keruly, J. C., Fiellin, D. A., Finkelstein, R., Barditch‐Crovo, P., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00003 · Cited by 119
Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users
Strain, E. C., Stitzer, M. L., Liebson, I. A., & Bigelow, G. E. (1994) · Psychopharmacology · doi:10.1007/bf02247469 · Cited by 108
Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function
Sacerdote, P., Franchi, S., Gerra, G., Leccese, V., Panerai, A. E., & Somaini, L. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.12.013 · Cited by 104
LAAM maintenance vs methadone maintenance for heroin dependence
Clark, N. C., Lintzeris, N., Gijsbers, A. J., Whelan, G., Dunlop, A. J., Ritter, A. J., & Ling, W. W. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002210 · Cited by 102
Schottenfeld, R. S., Chawarski, M. C., & Mazlan, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60954-x · Cited by 99
A meta-analysis comparing the effectiveness of buprenorphine and methadone
West, S. L., O’Neal, K. K., & Graham, C. W. (2000) · Journal of Substance Abuse · doi:10.1016/s0899-3289(01)00054-2 · Cited by 98
Prognostic Factors in Buprenorphine- versus Methadone-Maintained Patients
Schottenfeld, R. S., Pakes, J., & Kosten, T. R. (1998) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199801000-00006 · Cited by 98
Harris, A., Gospodarevskaya, E., & Ritter, A. J. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523010-00007 · Cited by 93
Soyka, M., Lieb, M., Kagerer, S., Zingg, C., Koller, G., Lehnert, P., Limmer, C., Küfner, H., & Hennig‐Fast, K. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31818a6d38 · Cited by 92
Neumann, A. M., Blondell, R. D., Jaanimägi, U., Giambrone, A. K., Homish, G. G., Lozano, J. R., Kowalik, U., & Azadfard, M. (2013) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.759872 · Cited by 90
Neri, S., Bruno, C. M., Pulvirenti, D., Malaguarnera, M., Italiano, C., Mauceri, B., Abate, G., Cilio, D., Calvagno, S., Tsami, A., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2239-x · Cited by 90
Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing
Johnson, R. E., Eissenberg, T., Stitzer, M. L., Strain, E. C., Liebson, I. A., & Bigelow, G. E. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01189-7 · Cited by 86
Marsch, L. A., Bickel, W. K., Badger, G. J., & Jacobs, E. A. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.08.011 · Cited by 84
Krook, A. L., Brørs, O., Dahlberg, J., Grouff, K., Magnus, P. M., Røysamb, E., & Waal, H. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00090.x · Cited by 81
Mitchell, T. B., White, J. M., Somogyi, A. A., & Bochner, F. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00764.x · Cited by 75
Lind, B. (2004) · The British Journal of Criminology · doi:10.1093/bjc/azh085 · Cited by 74
Comparison of Buprenorphine and Methadone in the Treatment of Opioid Dependence
Uehlinger, C., Déglon, J., Livoti, S., Petitjean, S. A., Waldvogel, D., & Ladewig, D. (1998) · European Addiction Research · doi:10.1159/000052036 · Cited by 72
Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth
Warden, D., Subramaniam, G., Carmody, T. J., WOODY, G. E., Minhajuddin, A., Poole, S. A., Potter, J. S., Fishman, M. J., Bogenschutz, M. P., Patkar, A. A., et al. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.04.011 · Cited by 72
Meader, N. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.12.008 · Cited by 59
Ahmadi, J., Ahmadi, K., & Ohaeri, J. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01218.x · Cited by 58
Lintzeris, N., Ritter, A. J., Panjari, M., Clark, N. C., Kutin, J. J., & Bammer, G. (2004) · American Journal on Addictions · doi:10.1080/10550490490440799 · Cited by 56
Buprenorphine: an alternative to methadone for heroin dependence treatment.
Resnick, R. B., Galanter, M. S., Pycha, C., Cohen, A., Grandison, P., & Flood, N. V. (1992) · PubMed · Cited by 55
Jones, H. E., O’Grady, K. E., Johnson, R. E., Vélez, M. L., & Jansson, L. M. (2010) · Substance Use & Misuse · doi:10.3109/10826084.2010.484474 · Cited by 55
Methadone versus buprenorphine maintenance for the treatment of heroin-dependent outpatients
Ahmadi, J. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00024-2 · Cited by 52
Desipramine in Opioid-Dependent Cocaine Abusers Maintained on Buprenorphine vs Methadone
Oliveto, A. H., Feingold, A., Schottenfeld, R. S., Jatlow, P. I., & Kosten, T. R. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.9.812 · Cited by 52
Comparison of Buprenorphine and Methadone Maintenance in Opiate Addicts
Eder, H., Fischer, G., Gombas, W., Jagsch, R., Stühlinger, G., & Kasper, S. F. (1998) · European Addiction Research · doi:10.1159/000052034 · Cited by 52
Jones, H. E., Johnson, R. E., Jasinski, D. R., & Milio, L. A. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.08.027 · Cited by 51
Kamien, J. B., Branstetter, S. A., & Amass, L. (2008) · Heroin addiction and related clinical problems · Cited by 50
Cropsey, K. L., Lane, P. S., Hale, G. J., Jackson, D. O., Clark, C. B., Ingersoll, K. S., Islam, M. A., & Stitzer, M. L. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.06.021 · Cited by 47
Opioid maintenance: a comparative review of pharmacological strategies
White, J. M., & Lopatko, O. V. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.1.1 · Cited by 47
Retention in methadone and buprenorphine treatment among African Americans
Gryczynski, J., Mitchell, S. G., Jaffe, J. H., Kelly, S. M., Myers, C. P., O’Grady, K. E., Olsen, Y. K., & Schwartz, R. P. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2013.02.008 · Cited by 46
Funada, M. (2003) · PubMed · Cited by 46
Lott, D. C., Strain, E. C., Brooner, R. K., Bigelow, G. E., & Johnson, R. E. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.04.005 · Cited by 40
Evaluation of an injection depot formulation of buprenorphine: placebo comparison
Sigmon, S. C., Wong, C. J., Chausmer, A. L., Liebson, I. A., & Bigelow, G. E. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00834.x · Cited by 39
A controlled trial of buprenorphine treatment for opium dependence: the first experience from Iran
Ahmadi, J. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00202-2 · Cited by 35
Twelve-month maintenance treatment of opium-dependent patients
Ahmadi, J., Babaeebeigi, M., Alishahi, M., Maany, I., & Hidari, T. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00141-7 · Cited by 34
Mattick, R. P., Oliphant, D., Ward, J., & Hall, W. (1998) · Cited by 33
Self-citationSubstitution with Buprenorphine in Methadone- and Morphine Sulfate-Dependent Patients
Bouchez, J., Beauverie, P., & Touzeau, D. (1998) · European Addiction Research · doi:10.1159/000052035 · Cited by 31
Cocaine Use in Buprenorphine-vs. Methadone-Maintained Patients
Oliveto, A. H., Kosten, T. R., Schottenfeld, R. S., Ziedonis, D. M., & Falcioni, J. (1994) · American Journal on Addictions · doi:10.1111/j.1521-0391.1994.tb00225.x · Cited by 30
Soyka, M., Träder, A., Klotsche, J., Backmund, M., Bühringer, G., Rehm, J., & Wittchen, H. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31822cd446 · Cited by 29
Stine, S. M., & Kosten, T. R. (1994) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999409109183 · Cited by 27
Buprenorphine maintenance treatment of heroin dependence: the first experience from Iran
Ahmadi, J. (2002) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(02)00222-2 · Cited by 26
McKeganey, N., Russell, C., & Cockayne, L. (2012) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2012.04.003 · Cited by 25
Depression Predicts Higher Rates of Heroin Use on Desipramine with Buprenorphine than with Methadone
Kosten, T. R., Falcioni, J., Oliveto, A. H., & Feingold, A. (2004) · American Journal on Addictions · doi:10.1080/10550490490435966 · Cited by 21
[Buprenorphine and methadone to opiate addicts--a randomized trial].
Kristensen, Ø., Espegren, O., Åsland, R., Jakobsen, E., Lie, Ø., & Seiler, S. (2005) · PubMed · Cited by 20
Pinto, H., Rumball, D., Maskrey, V., & Holland, R. (2008) · Journal of Substance Use · doi:10.1080/14659890701538810 · Cited by 14
Research works printed but not linked: 1
- Bond, 2004, A randomised comparison of methadone against buprenorphine in the treatment of opioid dependency: a feasibility study, International Journal of Pharmacy Practice, Supplement 2004, R52
Cited by
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7103a1 · Cited by 1,886
Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017) · BMJ · doi:10.1136/bmj.j1550 · Cited by 1,816
Degenhardt, L., Charlson, F., Ferrari, A., Santomauro, D., Erskine, H., Mantilla-Herrara, A., Whiteford, H., Leung, J., Naghavi, M., Griswold, M., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30337-7 · Cited by 1,572
Metadata
- Authors
- Mattick, R. P., Breen, C., Kimber, J., & Davoli, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2014-02-06
- Volume
- 2014
- Issue
- 2
- Pages
- CD002207-CD002207
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2132974770
- Cited by
- 2,274
- References
- 102
- FWCI
- 144.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.